Zhitong Finance App News, Baike Biotech (688276.SH) issued an announcement. The company recently received the “Notice of Acceptance” of the clinical trial application for a recombinant human anti-respiratory syncytial virus monoclonal antibody injection combination preparation (“RSV antibody”) issued by the State Drug Administration.

Zhitongcaijing · 2d ago
Zhitong Finance App News, Baike Biotech (688276.SH) issued an announcement. The company recently received the “Notice of Acceptance” of the clinical trial application for a recombinant human anti-respiratory syncytial virus monoclonal antibody injection combination preparation (“RSV antibody”) issued by the State Drug Administration.